Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Roivant Sciences Ltd (ROIV)

485 + Investors. Track Smart Money conviction in ROIV. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +52
Streak
3Q ▲
Buyers last Q
62%

Smart Money Signals — ROIV

Based on 489 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added ROIV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
489 hedge funds hold ROIV right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +44% more funds vs a year ago

fund count last 6Q
+149 new funds entered over the past year (+44% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 62% buying

305 buying183 selling
Last quarter: 305 funds were net buyers (101 opened a brand new position + 204 added to an existing one). Only 183 were sellers (134 trimmed + 49 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+14 vs last Q)

new funds entering per quarter
Funds opening a new ROIV position: 62 → 108 → 87 → 101. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 36% long-term, 37% new

■ 36% conviction (2yr+) ■ 27% medium ■ 37% new
Of the 489 current holders: 176 (36%) held >2 years, 133 held 1–2 years, and 180 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +39% but shares only +8% — price-driven

Value
+38%
Shares
+7%
Last quarter: the total dollar value of institutional holdings rose +39%, but actual share count only changed +8%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

66 → 62 → 108 → 87 → 101 new funds/Q
New funds entering each quarter: 62 → 108 → 87 → 101. A growing number of institutions are discovering ROIV each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 43% veterans vs 41% newcomers

■ 43% veterans ■ 17% 1-2yr ■ 41% new
Entry-cohort mix of 507 holders: 216 (43%) are 2+ year veterans, 84 entered 1–2 years ago, and 207 (41%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 60% AUM from top-100 funds

60% from top-100 AUM funds
62 of 488 holders are among the 100 largest funds by AUM, controlling 60% of total institutional value in ROIV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.5
out of 10
Moderate Exit Risk
Exit risk score 4.5/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ROIV

In 2026 Q2, 305 hedge funds were net buyers of ROIV (101 opened a new position, 204 added to an existing one), while 183 reduced or exited (134 trimmed, 49 sold completely) — a 62% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 60% of total institutional value in ROIV is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +52 funds (more new holders than closures). Total institutional holders: 489.

Hedge Fund Ownership: ROIV

How many hedge funds hold ROIV — quarterly history vs. share price
Quarterly hedge fund ownership of ROIV vs. share price

Market Analysis: ROIV

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ROIV

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Roivant Sciences Ltd (ROIV) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ROIV has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 60d ago
ROIV
-1.9%
XLV
+8.1%

ROIV outperformed XLV by -10.0% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 15d ago
ROIV
-4.1%
XLV
+2.5%

Since the filing became public, ROIV outperformed XLV by -6.6% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Growing Institutional Interest

Quality funds are building positions — conviction is rising but not yet widespread.

21 top-rated funds 11 high-conviction
Consensus
5.8
/ 10
breadth
×
Elite
6.0
/ 10
conviction
Hedge Fund Positioning: ROIV
485 + Investors

Track Smart Money conviction in ROIV. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 485 437 10.98%
13F Shares 558M 535M 4.27%
Total Value $19.50B $14.45B 34.9%
New Positions 99 87 +12
Increased Positions 201 166 +35
Closed Positions 50 49 +1
Reduced Positions 128 131 -3
Total Calls 10 10 -
Total Puts 9 12 -25.0%
PUT/CALL Ratio 0.9 1.2 Neutral

Statistics: ROIV

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

485 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ROIV. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ROIV holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 QVT Financial LP 49.36% 23,723,074 $839.6M
2 Patient Square Capital LP 43.97% 8,020,928 $283.9M
3 Davern Capital Partners, LP 11.66% 1,932,904 $68.4M
4 Whitefort Capital Management, LP 8.89% 1,019,000 $36.1M
5 Darwin Global Management, Ltd. 6.23% 6,747,300 $234.3M
6 Affinity Asset Advisors, LLC 6.00% 3,750,000 $132.7M
7 BlackBarn Capital Partners LP 5.97% 2,000,000 $70.8M
8 Two Seas Capital LP 5.94% 8,475,356 $299.9M
9 ADAR1 Capital Management, LLC 5.11% 3,157,008 $111.7M
10 First Turn Management, LLC 5.04% 1,331,066 $47.1M
11 Penn Davis Mcfarland Inc 4.98% 1,580,191 $55.9M
12 Perceptive Advisors LLC 4.30% 8,085,461 $286.1M
13 Integral Health Asset Management, LLC 2.80% 2,000,000 $70.8M
14 Dorsey Wright & Associates 2.35% 391,662 $13.9M
15 Sandro Wealth Management LLC 2.30% 90,130 $3.2M
16 Stempoint Capital LP 2.12% 348,408 $12.3M
17 DME Capital Management, LP 1.95% 2,152,669 $76.2M
18 Rubric Capital Management LP 1.95% 6,000,000 $212.3M
19 Cache Advisors, LLC 1.62% 538,600 $19.1M
20 Sectoral Asset Management Inc 1.51% 61,100 $2.2M
21 AlphaCentric Advisors LLC 1.45% 48,355 $1.7M
22 Seven Fleet Capital Management LP 1.29% 220,126 $7.8M
23 Two Seas Capital LP 1.04% 1,482,600 $52.5M
24 Nearwater Capital Markets, Ltd 0.92% 1,500,000 $53.1M
25 Maverick Capital Ltd 0.88% 2,829,024 $100.1M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Roivant Sciences Ltd (ROIV)

What does the Smart Money Trend signal show for ROIV?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added ROIV than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ROIV?

More buyers than sellers — 62% buying: Last quarter: 305 funds were net buyers (101 opened a brand new position + 204 added to an existing one). Only 183 were sellers (134 trimmed + 49 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ROIV holders?

Elite ownership — 60% AUM from top-100 funds: 62 of 488 holders are among the 100 largest funds by AUM, controlling 60% of total institutional value in ROIV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ROIV?

Mixed — 36% long-term, 37% new: Of the 489 current holders: 176 (36%) held >2 years, 133 held 1–2 years, and 180 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Roivant Sciences Ltd (ROIV) following the 2026 Q2 hedge fund 13F filings?

As of today, ROIV has moved -4.1% since the 2026 Q2 13F filing date (August 14, 2026), compared to +2.5% for the XLV sector ETF — an outperformance of -6.6%. Since the quarter end (June 30, 2026), ROIV has gained -1.9% vs +8.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →